These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12706472

  • 1. Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM, Bettelli E.
    Eur J Pharmacol; 2003 Apr 25; 467(1-3):173-83. PubMed ID: 12706472
    [Abstract] [Full Text] [Related]

  • 2. The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM.
    Eur J Pharmacol; 2000 Jan 10; 387(2):233-44. PubMed ID: 10650165
    [Abstract] [Full Text] [Related]

  • 3. Gastroprotective effects of amtolmetin guacyl: a new non-steroidal anti-inflammatory drug that activates inducible gastric nitric oxide synthase.
    Coruzzi G, Coppelli G, Spaggiari S, Cavestro GM, Okolicsanyi L, Lo Giudice P, Pisano C, Tepperman BL.
    Dig Liver Dis; 2002 Jun 10; 34(6):403-10. PubMed ID: 12132787
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
    Tubaro E, Belogi L, Mezzadri CM.
    Arzneimittelforschung; 2001 Sep 10; 51(9):737-42. PubMed ID: 11642006
    [Abstract] [Full Text] [Related]

  • 5. Gastrosparing effect of new antiinflammatory drug amtolmetin guacyl in the rat: involvement of nitric oxide.
    Pisano C, Grandi D, Morini G, Coppelli G, Vesci L, Lo Giudice P, Pace S, Pacifici L, Longo A, Coruzzi G, Carminati P.
    Dig Dis Sci; 1999 Apr 10; 44(4):713-24. PubMed ID: 10219827
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defence systems. Comparison with non-selective and COX-2 selective NSAIDs.
    Kirkova M, Alexandova A, Kesiova M, Todorov S.
    Auton Autacoid Pharmacol; 2007 Apr 10; 27(2):99-104. PubMed ID: 17391279
    [Abstract] [Full Text] [Related]

  • 8. Gastroprotective effect and mechanism of amtolmetin guacyl in mice.
    Li YH, Li J, Huang Y, Lu XW, Jin Y.
    World J Gastroenterol; 2004 Dec 15; 10(24):3616-20. PubMed ID: 15534917
    [Abstract] [Full Text] [Related]

  • 9. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H, Amagase K, Takeuchi K.
    J Pharmacol Exp Ther; 2012 Nov 15; 343(2):270-7. PubMed ID: 22854201
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G, Montrone F, Lazzaroni M, Manzionna G, Caruso I.
    Ital J Gastroenterol Hepatol; 1999 Nov 15; 31(5):378-85. PubMed ID: 10470596
    [Abstract] [Full Text] [Related]

  • 13. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
    Tanaka A, Mizoguchi H, Hase S, Miyazawa T, Takeuchi K.
    Med Sci Monit; 2001 Nov 15; 7(5):869-77. PubMed ID: 11535926
    [Abstract] [Full Text] [Related]

  • 14. Gastric effects of the novel non-steroidal anti-inflammatory drug amtolmetin guacyl.
    Coruzzi G, Bertaccini G.
    Nutrition; 1999 Apr 15; 15(4):325-6. PubMed ID: 10319368
    [No Abstract] [Full Text] [Related]

  • 15. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats.
    Kolgazi M, Jahovic N, Yüksel M, Ercan F, Alican I.
    J Gastroenterol Hepatol; 2007 Nov 15; 22(11):1859-65. PubMed ID: 17914960
    [Abstract] [Full Text] [Related]

  • 16. Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.
    Jiang GL, Im WB, Donde Y, Wheeler LA.
    J Pharmacol Exp Ther; 2010 Dec 15; 335(3):546-52. PubMed ID: 20833794
    [Abstract] [Full Text] [Related]

  • 17. Amelioration of chronic ileitis by nitric oxide synthase inhibition.
    Miller MJ, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA.
    J Pharmacol Exp Ther; 1993 Jan 15; 264(1):11-6. PubMed ID: 7678645
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS, Gairola N, Kandpal M, Vadnerkar G, Bhatt L, Rathi B, Kadam SS.
    Eur J Med Chem; 2009 Oct 15; 44(10):3922-9. PubMed ID: 19442419
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of amtolmetin guacyl versus placebo diclofenac and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage.
    Riezzo G, Chiloiro M, Montanaro S.
    Dig Dis Sci; 2001 Aug 15; 46(8):1797-804. PubMed ID: 11508686
    [Abstract] [Full Text] [Related]

  • 20. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice.
    Wang X, Zhao L, Han T, Chen S, Wang J.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):339-48. PubMed ID: 17963744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.